Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8210640rdf:typepubmed:Citationlld:pubmed
pubmed-article:8210640lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:8210640lifeskim:mentionsumls-concept:C0001554lld:lifeskim
pubmed-article:8210640lifeskim:mentionsumls-concept:C0021083lld:lifeskim
pubmed-article:8210640lifeskim:mentionsumls-concept:C0085669lld:lifeskim
pubmed-article:8210640lifeskim:mentionsumls-concept:C0242596lld:lifeskim
pubmed-article:8210640lifeskim:mentionsumls-concept:C1273870lld:lifeskim
pubmed-article:8210640pubmed:dateCreated1993-11-18lld:pubmed
pubmed-article:8210640pubmed:languageenglld:pubmed
pubmed-article:8210640pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8210640pubmed:citationSubsetIMlld:pubmed
pubmed-article:8210640pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8210640pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8210640pubmed:statusMEDLINElld:pubmed
pubmed-article:8210640pubmed:issn0080-0015lld:pubmed
pubmed-article:8210640pubmed:authorpubmed-author:MandelliFFlld:pubmed
pubmed-article:8210640pubmed:authorpubmed-author:KOK CKClld:pubmed
pubmed-article:8210640pubmed:authorpubmed-author:GuariniAAlld:pubmed
pubmed-article:8210640pubmed:authorpubmed-author:GavostoFFlld:pubmed
pubmed-article:8210640pubmed:authorpubmed-author:MeloniGGlld:pubmed
pubmed-article:8210640pubmed:authorpubmed-author:TostoMMlld:pubmed
pubmed-article:8210640pubmed:authorpubmed-author:VignettiMMlld:pubmed
pubmed-article:8210640pubmed:authorpubmed-author:Gillio TosAAlld:pubmed
pubmed-article:8210640pubmed:authorpubmed-author:MarchisDDlld:pubmed
pubmed-article:8210640pubmed:issnTypePrintlld:pubmed
pubmed-article:8210640pubmed:volume131lld:pubmed
pubmed-article:8210640pubmed:ownerNLMlld:pubmed
pubmed-article:8210640pubmed:authorsCompleteYlld:pubmed
pubmed-article:8210640pubmed:pagination207-14lld:pubmed
pubmed-article:8210640pubmed:dateRevised2008-2-13lld:pubmed
pubmed-article:8210640pubmed:meshHeadingpubmed-meshheading:8210640-...lld:pubmed
pubmed-article:8210640pubmed:meshHeadingpubmed-meshheading:8210640-...lld:pubmed
pubmed-article:8210640pubmed:meshHeadingpubmed-meshheading:8210640-...lld:pubmed
pubmed-article:8210640pubmed:meshHeadingpubmed-meshheading:8210640-...lld:pubmed
pubmed-article:8210640pubmed:meshHeadingpubmed-meshheading:8210640-...lld:pubmed
pubmed-article:8210640pubmed:meshHeadingpubmed-meshheading:8210640-...lld:pubmed
pubmed-article:8210640pubmed:meshHeadingpubmed-meshheading:8210640-...lld:pubmed
pubmed-article:8210640pubmed:meshHeadingpubmed-meshheading:8210640-...lld:pubmed
pubmed-article:8210640pubmed:meshHeadingpubmed-meshheading:8210640-...lld:pubmed
pubmed-article:8210640pubmed:year1993lld:pubmed
pubmed-article:8210640pubmed:articleTitleInterleukin-2-based immunotherapy in the management of minimal residual disease in acute leukemia patients.lld:pubmed
pubmed-article:8210640pubmed:affiliationDipartimento di Scienze Biomediche e Oncologia Umana, University of Turin, Italy.lld:pubmed
pubmed-article:8210640pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8210640pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed